PROX1 was found to be overexpressed in 43% of colon cancer tissues, and its upregulation correlated with the downregulation of E-cadherin, advanced tumor staging, and the presence of lymph node metastasis (90). Here, PROX1 is linked to malignant colon neoplasm.